Accelagen
Biotechnology Research • 
United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Phone number | +18586788618 |
| Website | |
| SIC | 873 |
| Employees | 1-10 |
| Socials |
Key Contact at Accelagen
Chun Luo
President and CEO
About Accelagen
Accelagen is a fast growing Gene-to-Protein company. Accelagen’s gene-to-protein platform integrates the latest technologies of Baculovirus Expression Vector System (BEVS), E. coli expression, mammalian expression, Wave Bioreactors, Cell Factory, and AKTA chromatography systems, providing superior protein quality and accelerating the processes from gene to protein.
Accelagen revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Accelagen has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
Accelagen has never raised funding before.
Accelagen Tech Stack
Discover the technologies and tools that power Accelagen's digital infrastructure, from frameworks to analytics platforms.
Hosting panels
Editors
Hosting
Operating systems
SSL/TLS certificate authorities
Web servers
Web frameworks
South Africa
Germany
Netherlands
Singapore
Frequently asked questions
4.8
40,000 users
